A major advance in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This essential tumor protector protein is frequently disabled in several types of malignancies, resulting https://bookmarkingalpha.com/story21945769/nanobodies-restore-p53-the-new-pathway-for-malignant-management